Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

NARecruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 12, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
DiabetesType 2 DiabetesType 2 Diabetes Mellitus - Poor Control
Interventions
DEVICE

Continuous Glucose Monitor (CGM)

The first CGM sensor will be applied as directed during the first visit with a brief training by staff. Participant will be instructed to remove and replace the device every 14 days for the remainder of the 3-month trial period. Participant will also be instructed to scan the sensor three times daily. Compliance may be tracked via remote accessing of the blood glucose log on the online FreeStyle portal. CGM models used will include the Abbott FreeStyle Libre 2 and 3 and Dexcom G5, G6 and G7.

Trial Locations (1)

06520

RECRUITING

Fair Haven Community Health Care (FHCHC), New Haven

All Listed Sponsors
collaborator

Yale Office of Global Health

UNKNOWN

lead

Yale University

OTHER